|
New
Product Introduction
McGuff Pharmaceuticals, Inc. Launches
Magnesium Chloride Injection
McGuff Pharmaceuticals, Inc. (MPI) is pleased to announce the release
of Magnesium Chloride Injection as part of its strategic product mix.
The introduction of Magnesium Chloride Injection expands the company’s
small volume, sterile injectable product portfolio.
Magnesium Chloride Injection is indicated for use as an electrolyte
replenisher in magnesium deficiencies. MPI’s Magnesium Chloride
Injection consists of a 50mL volume of sterile, pyrogen free Magnesium
Chloride Hexahydrate (200 mg/mL) in a solution containing Sodium
Chloride (9 mg/mL), Benzyl Alcohol (1% as a preservative), and Water
for Injection. The product is used in intravenous admixtures in a
variety of therapies.
|
|
McGuff Pharmaceuticals, Inc. is focused
on providing small volume, sterile injectable products to the
physician and hospital markets. Through a unique combination of
technical capabilities, state of the art manufacturing facilities and
strong relationships with distribution partners, MPI fulfils it’s
objective of meeting patient and physician needs for high quality,
competitively priced, small volume injectable products. The
introduction of Magnesium Chloride Injection demonstrates our
commitment to these customers and markets.
 Return
to MPI Home Page
|
|
